Gapping down
In reaction to earnings/guidance:
- SONO -17.4% (also CFO to step down, names new CFO), RRGB -14.2%, SIX -12.6%, COOK -11%, HBI -10.5%, BMBL -8.9%, APP -7.3%, PAAS -7%, HIMX -6.8%, AKA -6.3%, ENS -4.8%, MQ -3.8%, FSM -3.8%, AVT -3.7%, ACVA -2.6%, WKME -2%, CAH -1.9%, SWIM -1.3%, CLBT -1.2%, WRBY -0.8%
Other news:
- ATNX -32.5% (prices $30 mln public offering of common stock and warrants)
- CERE -9.7% (commences $250 mln stock offering)
- SNY -9.2% (under pressure this morning amid concerns about litigation around recalled drug Zantac)
- GSK -8.5% (under pressure this morning amid concerns about litigation around recalled drug Zantac)
- BNL -5.7% (prices offering of 13.0 mln shares of common stock at $21.35 per share)
- MAIN -5.3% (commences $50 mln stock offering)
- LXU -3.1% (prices offering of 13.5 mln shares of common stock at $13.00 per share by selling shareholders)
- LNDC -2.9% (rebrands as Lifecore Biomedical names new CEO)
- KRG -2.8% (increases dividend)
- KIDS -2.6% (stock offering)
- HLN -2.6% (under pressure this morning amid concerns about litigation around recalled drug Zantac)
- CINC -1.6% (prices offering of common stock and pre-funded warrants)
- ZEV -1.3% (files $250 mln mixed securities shelf offering)
- VRNA -1.3% (prices offering of $12.4 mln shares of common stock at $10.50 per share)
- DCPH -1% (announces publication of INTRIGUE Phase 3 study of QINLOCK)
Analyst comments:
- PSFE -3.2% (downgraded to Sector Perform from Outperform at RBC Capital Mkt; downgraded to Underperform from Neutral at Credit Suisse)
- LOW -1.8% (downgraded to Neutral from Buy at Citigroup)